Viventa · AI Transformation for Life Sciences · 2026
Advisory, development & integration, and managed services built end-to-end for pharma and biotech. We design the agent workflow, ship it inside your perimeter, and run it under GxP-grade governance.
Operating model
One vertical team across advise · build · run. Same accountability from boardroom to production.
Why now the market context
$200B+
Forecast enterprise spend across AI transformation services by 2030. (Nasscom / McKinsey)
~95%
Of enterprise GenAI pilots fail to reach production. The gap is integration and governance not models.
200+
FDA promotion enforcement letters issued in 2025 the highest in ~25 years. Governance is structural.
50–65%
Reported reduction in regulatory submission timelines from AI automation across leading programs.
The transformation map
Most providers pick a lane: a consultancy with no shipped agents, a systems integrator with no strategy, an MSP with no domain. Viventa runs all three stages on a single vertical team.
Stage 01
AI strategy & opportunity mapping
Stage 02
Architecture & model orchestration
Data for AI services
Agent development
Stage 03
Deployment, ops & monitoring
AI security
Responsible AI & governance
Stages and categories of enterprise AI transformation, by Viventa service offering.
Operating principles
The market is full of pilots that die in PowerPoint. We are built for the workloads that move from a regulated science team into a production agent and stay there.
01
Generalist consultancies bolt AI onto slide decks. We are built end-to-end for the life-sciences value chain regulated data, evidence provenance, MLR.
02
We don't hand you a strategy and disappear. The same team that maps the opportunity ships the agents and operates them in production.
03
Lineage, human-in-the-loop, and zero-trust access aren't bolt-ons. They are properties of the platform, designed against the post-2025 enforcement regime.
04
Your evidence, your perimeter, your models. Deploy inside your VPC or sovereign cloud. No data leaves your control.
A congress to cover. A regulatory submission to compress. A medical-information backlog to clear. We'll scope the agent, ship it inside your perimeter, and operate it under your governance.